全文获取类型
收费全文 | 18673篇 |
免费 | 919篇 |
国内免费 | 811篇 |
出版年
2024年 | 26篇 |
2023年 | 226篇 |
2022年 | 260篇 |
2021年 | 487篇 |
2020年 | 505篇 |
2019年 | 738篇 |
2018年 | 629篇 |
2017年 | 379篇 |
2016年 | 397篇 |
2015年 | 588篇 |
2014年 | 1276篇 |
2013年 | 1380篇 |
2012年 | 932篇 |
2011年 | 1329篇 |
2010年 | 941篇 |
2009年 | 915篇 |
2008年 | 973篇 |
2007年 | 973篇 |
2006年 | 888篇 |
2005年 | 809篇 |
2004年 | 701篇 |
2003年 | 610篇 |
2002年 | 516篇 |
2001年 | 292篇 |
2000年 | 307篇 |
1999年 | 268篇 |
1998年 | 245篇 |
1997年 | 199篇 |
1996年 | 205篇 |
1995年 | 186篇 |
1994年 | 198篇 |
1993年 | 166篇 |
1992年 | 167篇 |
1991年 | 156篇 |
1990年 | 118篇 |
1989年 | 100篇 |
1988年 | 85篇 |
1987年 | 95篇 |
1986年 | 87篇 |
1985年 | 141篇 |
1984年 | 142篇 |
1983年 | 88篇 |
1982年 | 121篇 |
1981年 | 112篇 |
1980年 | 107篇 |
1979年 | 76篇 |
1978年 | 64篇 |
1977年 | 47篇 |
1976年 | 54篇 |
1974年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
91.
Predictive indicators for the therapeutic effect of OK-432 in patients with chronic active type B hepatitis 总被引:1,自引:0,他引:1
Twenty-two patients with chronic type B hepatitis were treated with OK-432. Immunological parameters were serially measured to find predictive indicators for the seroconversion from hepatitis B envelope antigen(HBe Ag) to anti-HBe. In patients who achieved the disappearance of HBe Ag associated with or without the appearance of anti-HBe, the numbers of CD8+DR+ and CD4+DR+T cells in peripheral blood increased gradually during OK-432 therapy and then reduced subsequently to the seroconversion from HBe Ag positive to anti-HBe positive. Increases of DR-positive T cells in numbers were significantly correlated with increased amounts of IFN- produced in response toin vitro OK-432 stimulation.In vitro OK-432-stimulated IFN- production and the increase of CD8+DR+T cells in number in peripheral blood could be proposed as predictive indicators for the disappearance of HBe Ag. 相似文献
92.
Ayumi Ohsaki Yoshihisa Kasetani Yukihiro Asaka Kozo Shibata Takashi Tokoroyama Takashi Kubota 《Phytochemistry》1991,30(12):4075-4077
Three trans-clerodane diterpenoids, pilosanol A, B and C, the last compound being a glucoside, have been isolated from the roots of Portulaca pilosa. They show a marked contrast in skeletal type with the constituents of aerial part. Evolutionary changes in the biosynthetic abilities of Portulaca species is discussed. 相似文献
93.
The absolute configuration at C-12 of pittosporatobiraside A and B isolated from the leaves of Pittosporum tobira was determined to be S on the basis of the exciton chirality of their dibenzoate derivative. The structures of the two glycosides were thus established to be (1S,9S,10S,11S,12S,14R,16R)-12-[(Z)-2-methyl-1-oxo-2-butenyl]-6,14-dimethyl-2-methylene-9-(1-methylethyl)-15,17-dioxatricyclo[8.7.0.011,16]heptadec-5-en-13-one and (1S,9S,10S,11S,12S,14R,16R)-12-(3-methyl-1-oxo-2-butenyl)-6,14-dimethyl-2-methylene-9-(1-methylethyl)-15,17-dioxatricyclo [8.7.0.011,16]heptadec-5-en-13-one, respectively. 相似文献
94.
95.
K. Toriyama J. C. Stein M. E. Nasrallah J. B. Nasrallah 《TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik》1991,81(6):769-776
Summary An SLG gene derived from the S-locus and encoding and S-locus-specific glycoprotein of Brassica campestris L. was introduced via Agrobacterium-mediated transformation into B. oleracea L. A self-incompatible hybrid and another with partial self-compatibility were used as recipients. The transgenic plants were altered in their pollen-stigma interaction and were fully compatible upon self-pollination. Reciprocal crosses between the transgenic plants and untransformed control plants indicated that the stigma reaction was changed in one recipient strain while the pollen reaction was altered in the other. Due to interspecific incompatibility, we could not demonstrate whether or not the introduced SLG gene confers a new allelic specificity in the transgenic plants. Our results show that the introduced SLG gene perturbs the self-incompatibility phenotype of stigma and pollen. 相似文献
96.
S. J. Ochatt 《Plant Cell, Tissue and Organ Culture》1991,25(2):161-167
Leaf protoplasts of axenic shoot cultures of Lonicera nitida cv Maigrun underwent sustained division to give multicellular colonies (microcalli) on a modified, ammonium-free MS (Murashige & Skoog) medium containing 0.5 mg l-1 NAA (1-naphthaleneacetic acid), 1.0 mg l-1 BAP (6-benzylaminopurine) and 150 mg l-1 casein enzymatic hydrolysate. Callus was produced upon transfer of cell colonies to MS medium with 2.0 mg l-1 NAA and 0.2 mg l-1 BAP. About 110 days from isolation protoplast-derived shoots were regenerated on a half-strength MS medium with 0.01 mg l-1 NAA, 5.0 mg l-1 BAP, 0.5 mg l-1 zeatin and a complex mixture of group B vitamins. The replacement of such mixture by 250 mg l-1 casein enzymatic hydrolysate promoted rhizogenesis in calli, with shoot buds being subsequently regenerated from the protoplast-derived roots. Micropropagation of protoplast-derived shoots (of either origin) was difficult, due to a strong apical dominance, but could be accomplished by transferring single-node explants to half-strength MS medium with 1.5 mg l-1 BAP. Such shoots were, in turn, successfully rooted and transferred to the glasshouse where they completed acclimatization.Abbreviations BAP
6-benzylaminopurine
- CPW
Power et al. (1989) medium
- 2,4-D
2,4-dichlorophenoxyacetic acid
- FDA
fluorescein diacetate
- F.P.E.
final plating efficiency
- f.wt.
fresh weight
- IAA
4-indole-3yl-acetic acid
- IBA
4-indole-3yl-butyric acid
- I.P.E.
initial plating efficiency
- MES
2-N-morpholinoethane sulfonic acid
- M.P.E.
intermediate plating efficiency
- MS
Murashige & Skoog (1962) medium
- NAA
1-naphthaleneacetic acid
- PVP-10
polyvinylpirrolidone
- Av MW 10,000, TIBA
2,3,5-tri-iodobenzoic acid
- Z
zeatin 相似文献
97.
本文用哺乳动物细胞系表达的乙型肝炎病毒表面抗原(HBsAg),制备了HBsAg的微团化(Micelle)和免疫剂激复合物(Immune-stimulating Complexes,简称ISCOMS)两种形式的抗原。在电镜下观察,微团化抗原是由球形亚单位颗粒组成直径100~150nm的较原颗粒大得多的大颗粒,在蔗糖中的浮力密度为1.24g/ml;而ISCOMS在电镜下为直径30~40nm左右稍大于原颗粒的多面体形态颗粒。SDS-PAGE分析表明,这两种形式的颗粒都是由HBsAg的P23和GP27蛋白所组成。 小鼠免疫接种结果显示,ISCOMS的免疫原性优于微团化抗原,后者又优于原22nm HBsAg颗粒。在抗体产生的速度和强度上,ISCOMS组显著优于微团化抗原组,而微团化抗原组略优于22nm HBsAg组。 ISCOMS的免疫性强,抗体产生早,强度高,又易于制备,而且不需要使用氢氧化铝胶佐剂,有可能发展成为一种新一代的乙型肝炎疫苗。 相似文献
98.
乙型肝炎病毒(HBV)的核心抗原基因(C基因)编码185个氨基酸残基,在原核细胞或痘苗病毒系统中能表达并装配成27nm大小的核心抗原(HBcAg)多聚体颗粒。已证实HBV C基因3′端编码近40个氨基酸的碱基序列,不是表达形成HBcAg颗粒所必需的。用外源基因替换这部分序列,已表达出表面带有外源基因产物的杂合颗粒,它具有很好的免疫原性,成为新型的基因工程多决定簇颗粒载体疫苗。但我们的实验中发现,用另外的外源基因替换3′端序列能显著影响HBV C基因在大肠杆菌中的表达,不同组成的外源基因其影响程度有所不同。 相似文献
99.
100.